Evidence map›Paper›PMID 24133213›Full record

ArticleThe Journal of biological chemistry2013

Analysis of Drosophila glucuronyl C5-epimerase: implications for developmental roles of heparan sulfate sulfation compensation and 2-O-sulfated glucuronic acid.

Katsufumi Dejima, Masahiko Takemura, Eriko Nakato, Jesse Peterson, Yoshiki Hayashi, Akiko Kinoshita-Toyoda, Hidenao Toyoda, Hiroshi Nakato

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Structural and functional study of D-glucuronyl C5-epimerase.The Journal of biological chemistry · 2015
    Article
  17. Article
  18. D-glucuronyl C5-epimerase cell type specifically affects angiogenesis pathway in different prostate cancer cells.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Katsufumi DejimaFrom the Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, Minnesota 55455 and.
Masahiko Takemura
Eriko Nakato
Jesse Peterson
Yoshiki Hayashi
Akiko Kinoshita-Toyoda
Hidenao Toyoda
Hiroshi Nakato
University of Minnesota · USRitsumeikan University · JP

Funding

Genetic Study of Heparan Sulfate Function in DevelopmentR01HD042769 · NICHD · UNIVERSITY OF MINNESOTA TWIN CITIES · PI NAKATO, HIROSHI · 2003 to 2013
$2.6M
NICHD NIH HHS R01 HD042769
6 · The paper itself

Abstract

During the biosynthesis of heparan sulfate (HS), glucuronyl C5-epimerase (Hsepi) catalyzes C5-epimerization of glucuronic acid (GlcA), converting it to iduronic acid (IdoA). Because HS 2-O-sulfotransferase (Hs2st) shows a strong substrate preference for IdoA over GlcA, C5-epimerization is required for normal HS sulfation. However, the physiological significance of C5-epimerization remains elusive. To understand the role of Hsepi in development, we isolated Drosophila Hsepi mutants. Homozygous mutants are viable and fertile with only minor morphological defects, including the formation of an ectopic crossvein in the wing, but they have a short lifespan. We propose that two mechanisms contribute to the mild phenotypes of Hsepi mutants: HS sulfation compensation and possible developmental roles of 2-O-sulfated GlcA (GlcA2S). HS disaccharide analysis showed that loss of Hsepi resulted in a significant impairment of 2-O-sulfation and induced compensatory increases in N- and 6-O-sulfation. Simultaneous block of Hsepi and HS 6-O-sulfotransferase (Hs6st) activity disrupted tracheoblast formation, a well established FGF-dependent process. This result suggests that the increase in 6-O-sulfation in Hsepi mutants is critical for the rescue of FGF signaling. We also found that the ectopic crossvein phenotype can be induced by expression of a mutant form of Hs2st with a strong substrate preference for GlcA-containing units, suggesting that this phenotype is associated with abnormal GlcA 2-O-sulfation. Finally, we show that Hsepi formed a complex with Hs2st and Hs6st in S2 cells, raising the possibility that this complex formation contributes to the close functional relationships between these enzymes.

Indexed as

AnimalsCarbohydrate EpimerasesDrosophilaDrosophila ProteinsFibroblast Growth FactorsGene Expression Regulation, DevelopmentalGlucuronatesGlucuronic AcidHeparan SulfateIduronic AcidLongevityMutagenesis, Site-DirectedMutationSignal TransductionSulfotransferasesCarbohydrate EpimerasesDrosophila ProteinsFibroblast Growth FactorsGlucuronatesGlucuronic Acidglucuronic acid 2-sulfateHeparan Sulfateheparan-sulfate 2-sulfotransferaseheparan sulfate 6-O-sulfotransferaseheparan sulfate C5-epimerase, DrosophilaIduronic AcidSulfotransferasesC5-EpimeraseDrosophilaFibroblast Growth Factor (FGF)GagosomeGeneticsHeparan SulfateImmunohistochemistrySulfation Compensation

Identifiers

PMID24133213
PMCPMC3843053
OpenAlexW2120001299

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.